Rocket Pharmaceuticals, Inc. RCKT
2.60
(0.09)
(3.35%)
as of 25 Sep
- Market cap
- $300.8M
- P/E
- 0.0×
Follow RCKT
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
6.38 | 9.30 | 7.80 | 9.29 | 17.69 | 14.94 | 16.81 | 13.60 | 4.19 | 18.23 |
Net Debt/EBITDA |
0.77 | 1.34 | 1.40 | 1.53 | 2.27 | 3.32 | 3.41 | 2.32 | 0.93 | 10.33 |
Debt/Assets |
5.86% | 3.67% | 3.42% | 3.95% | 4.37% | 9.97% | 12.36% | 16.49% | 0.00% | 37.76% |
Debt/Equity |
0.07 | 0.04 | 0.04 | 0.04 | 0.05 | 0.12 | 0.15 | 0.21 | 0.00 | 0.67 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.85 | 0.81 | 0.79 | 0.80 | 0.72 | 0.53 | 0.84 | 0.72 | 0.82 | 0.73 |
Capex/Depreciation |
(0.04) | (0.63) | (2.32) | (1.33) | (1.42) | (3.02) | (54.62) | (4.34) | (3.73) | (5.00) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (60.27%) | (54.14%) | (50.01%) | (46.98%) | (35.29%) | (34.46%) | (30.83%) | (88.66%) | (82.92%) | (8.32%) | |
| (52.00%) | (47.30%) | (43.93%) | (42.31%) | (31.08%) | (29.02%) | (24.79%) | (54.90%) | (26.14%) | (6.23%) | |
ROIC |
(134.54%) | (154.83%) | (116.96%) | (90.42%) | (119.22%) | (105.28%) | (96.76%) | (149.47%) | 0.00% | 0.00% |
Return on Tangible Assets |
(117.00%) | (69.13%) | (66.58%) | (62.69%) | (43.11%) | (29.48%) | (24.23%) | (38.07%) | (126.97%) | (6.19%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.19 | 0.12 | 0.11 | 0.12 | 0.06 | 0.05 | 0.08 | 0.12 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(1.71) | (2.27) | (2.52) | (2.74) | (2.04) | (1.72) | (1.79) | (1.40) | (2.46) | (0.85) |
Cash per Share |
1.70 | 3.93 | 4.44 | 5.23 | 6.15 | 8.72 | 6.21 | 5.22 | 2.67 | 18.51 |
Shareholders Equity per Share |
2.49 | 4.89 | 5.86 | 7.19 | 7.19 | 9.09 | 6.27 | 4.93 | 2.28 | 10.71 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.49 | 4.89 | 5.86 | 7.19 | 7.19 | 9.09 | 6.27 | 4.93 | 2.28 | 10.71 |
Free Cash Flow |
(190.45) | (215.59) | (211.35) | (186.50) | (128.78) | (95.25) | (87.93) | (55.22) | (16.72) | (5.84) |
Working Capital |
162.53 | 337.50 | 329.72 | 324.89 | 369.89 | 454.73 | 289.45 | 193.72 | 14.43 | 121.31 |
Capital Expenditures |
(0.44) | (5.86) | (16.44) | (8.36) | (7.62) | (20.61) | (23.27) | (1.43) | (0.76) | (0.33) |
Net Current Asset Value |
139.51 | 313.72 | 304.46 | 301.94 | 349.76 | 400.04 | 242.93 | 151.81 | 14.33 | 71.87 |
| Other line items | ||||||||||
Quick Ratio |
6.25 | 9.15 | 7.69 | 9.10 | 17.54 | 14.80 | 16.61 | 13.38 | 4.01 | 17.96 |
Depreciation/Fixed assets |
0.40 | 0.25 | 0.18 | 0.22 | 0.24 | 0.36 | 0.01 | 0.16 | 0.21 | 0.06 |
Cash ROIC |
(44.94%) | (28.83%) | (26.45%) | (23.87%) | (16.58%) | (8.98%) | (14.33%) | (12.65%) | (50.35%) | (2.67%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1.71) | (2.21) | (2.32) | (2.61) | (1.92) | (1.35) | (1.32) | (1.37) | (2.35) | (0.81) |
Capex per Share |
0.00 | (0.06) | (0.20) | (0.12) | (0.12) | (0.37) | (0.47) | (0.04) | (0.11) | (0.05) |
Average Payables |
32.56 | 41.81 | 41.22 | 28.14 | 22.54 | 21.41 | 16.36 | 9.95 | 3.06 | 1.61 |
Average Assets |
429.07 | 547.02 | 559.07 | 524.41 | 543.92 | 481.47 | 311.72 | 135.73 | 74.90 | 121.48 |
Average Common Equity |
370.23 | 477.90 | 491.13 | 472.21 | 479.12 | 405.41 | 250.67 | 84.05 | 23.61 | 90.99 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates